TrialHuman vaccines & immunotherapeutics2020

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.

Mark A Matson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.